摘要
目的 分析探讨肝癌病理诊断中肝组织雌激素受体α表达的临床价值,进一步为临床诊治肝癌提供理论指导与依 据。方法 选择2012年10月-2015年9月在我院接受治疗的肝癌患者25例为此次研究实验组,选取同时期来院体检的 25例患者为对照组,实验组患者取其肝癌组织和癌旁标本、对照组取其正常肝脏组织标本,采用免疫组化的方法对 肝组织雌激素受体α进行检测,探讨其表达情况。结果 经过检测并统计发现,正常肝脏组织的肝组织雌激素受体 α相对表达量为56.5%,肝癌患者的癌旁组织相对表达量为10.4%,而肝癌变组织的相对表达量为0%。结论 由结果 可见,肝组织雌激素受体α的表达量能够将正常的肝组织和肝癌组织鉴别出来,并且可将肝癌组织和癌旁组织划分 出来,临床意义突出,值得进一步推广和使用。
Objective To analyze and discuss the clinical value of estrogen receptor α expression in liver tissue in pathological diagnosis of liver cancer, so as to provide theoretical guidance and basis for clinical diagnosis and treatment of liver cancer. Methods 25 patients with liver cancer treated in our hospital from October 2012 to September -2015 were selected as the experimental group, 25 cases of physical examination at the same period were selected as control group. The expression of estrogen receptor α in liver tissue was detected by immunohistochemistry, that was studied. Results After the examination and statistics found that the normal liver tissue of liver tissue relative expression of estrogen receptor alpha 56.5%, hepatocellular carcinoma tissues relative expression was 10.4%, and the relative expression of hepatocellular carcinoma tissues was 0%. Conclusion The expression of estrogen receptor alpha in liver tissue can be identified in liver tissue and liver tissue of normal, and the liver tissue and paracancerous tissue division, to highlight the clinical significance, is worthy of further promotion and application.
【关键词】肝癌;病理诊断;肝组织雌激素受体α表达;检测意义分析
【中图分类号】R735.7
【文献标识码】A
【DOI】10.3969/j.issn.1009-3257.2017.05.011
前言
肝癌是我国常见的恶性肿瘤之一,一般发生在肝 细胞或肝内胆管上皮细胞的恶性肿瘤[1]。据统计,我 国肝癌的每年人数为10万多,在恶性肿瘤死亡顺位 中占第2位,在城市中仅次于肺癌;农村中仅次于胃 癌[2]。因此说肝癌已经成为我国死亡率最高的恶性肿 瘤之一。肝癌的早期症状缺乏,而确诊时往往已是 中、晚期了,因此治疗效果不佳,及早发现确诊对于 提高患者的生存率和生活质量至关重要[3-4]。本次研 究为分析探讨肝癌病理诊断中肝组织雌激素受体α表 达的临床价值,进一步为临床诊治肝癌提供理论指导 与依据,特进行了相关研究,现报道如下。
罕少疾病杂志
第24卷, 第 5 期
2019年11月
相关文章